University of Nebraska

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Nebraska sits in the top decile of US sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count).

407 total trials 51 currently recruiting 261 completed early-phase tilt top decile by trial count

University of Nebraska: 407 sponsored US clinical trials, 51 recruiting.

University of Nebraska sponsors 407 registered US clinical trials on ClinicalTrials.gov, 51 of them currently recruiting, and 261 completed. 31 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Peripheral Arterial Disease, with 7 trials.

Top-decile sponsor footprint

University of Nebraska ranks in the top decile of sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 36/100

261 of 332 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

407 total, page 3 of 9

COMPLETED NA

Optimizing Movement After Anterior Cruciate Ligament Injury

NCT05363683
COMPLETED NA

Reducing Work-related Screen Time in Health Care Workers During Leisure Time

NCT05106647
COMPLETED

Differences in Length of Telomere in Food Addicted vs Non Food Addicted Persons

NCT05649189
COMPLETED

Strength, Aging, and Memory in Prostate Cancer

NCT04852224
TERMINATED NA

Comparison of Gait in Syndesmosis Injuries Treated With Screw Fixation vs Suture Button

NCT04972578
COMPLETED NA

Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation

NCT05038943
TERMINATED NA

Family Connections: Cultural Adaptation and Feasibility Testing for Rural Latino Communities

NCT04731506
COMPLETED NA

Effect of Smartphone Application on Reducing Localized Inflammation in Periodontal Maintenance Patients

NCT04546295
TERMINATED

A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19 Infection

NCT04807075
TERMINATED Phase 3

The Role of Platelet Rich Plasma for Erectile Dysfunction

NCT04357353
COMPLETED Phase 1

Smith-Lemli-Opitz Syndrome and Cholic Acid

NCT03720990
TERMINATED Phase 2

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

NCT04141995
COMPLETED

Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19

NCT04637295
COMPLETED NA

The Patterns of Activity and Cognition During Treatment (PACT) Study

NCT04562987
COMPLETED

Reliability of Sacral Slope, Pelvic Femoral Motion and Cup Ante-inclination on AP Pelvic Radiographs in Healthy Pts

NCT04687306
COMPLETED NA

Safety and Effectiveness of NRP for DCD Heart Transplantation

NCT04626284
TERMINATED Phase 3

The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF

NCT04650893
TERMINATED Phase 1

Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients

NCT04445337
TERMINATED Early Phase 1

Pain Management Following Sinus Surgery

NCT03822962
COMPLETED

Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors

NCT04472286
COMPLETED Phase 4

Sufentanil Infusion vs Sufentanil Bolus

NCT04226495
TERMINATED Phase 1

A Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC

NCT03963414
COMPLETED Phase 1

Healthy Body, Healthy Bones After Bariatric Surgery Trial

NCT04279392
COMPLETED

Evaluation of Changes in Brain Connectivity After Tumor Resection

NCT04536142
COMPLETED NA

Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant

NCT04030312
TERMINATED NA

Longitudinal Analysis of Gait Variability to Predict Falls in Parkinson's Disease

NCT04339543
TERMINATED Phase 2

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

NCT02700841
COMPLETED NA

Mobile App to Promote Family Caregiver Engagement in the Intensive Care Unit

NCT05157919
COMPLETED

Validity of Physical Activity Questionnaires in Persons Pursuing Bariatric Surgery

NCT03981978
COMPLETED NA

Mechanisms of Fall Resistance to Diverse Slipping Conditions

NCT03758040
COMPLETED NA

Variability and Specificity in Reactive Stabilization Movements to Diverse Slip Perturbations

NCT03755336
COMPLETED NA

Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant

NCT04541667
COMPLETED NA

Self-Management Interventions Using Mobile Health for the Multimorbid

NCT04566107
COMPLETED Phase 4

Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE

NCT03998176
COMPLETED NA

Study on Physical Activity's Relationship With Cancer and Cognition

NCT03980626
TERMINATED NA

Sustaining the Reach of a Scalable Weight Loss Intervention Through Financial Incentives

NCT04225234
COMPLETED

Comparison of a Non-linear Analysis of Balance During the mBESS to the Sway Balance Application

NCT03994952
COMPLETED Phase 1

ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

NCT03932643
COMPLETED Phase 2

Impact of Evolocumab in Cardiac Transplant Patients With CAV

NCT03944577
TERMINATED Phase 4

Effect of Vitamin D Supplementation on Balance in CKD

NCT03710161
COMPLETED NA

Animal Assisted Interactions With Animal Robot in the Intensive Care Unit (ICU)

NCT05075395
COMPLETED NA

Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

NCT03724331
COMPLETED NA

A SMART Design to Improve Sleep Disturbance in Adolescents With Neurodevelopmental Disorders

NCT03730194
TERMINATED NA

Increasing Caregiver and Patient Engagement Through PHR Use

NCT03659565
COMPLETED

Measurement of Beta Cell Death in Individuals With Cystic Fibrosis

NCT03713437
COMPLETED NA

Mental Health Intervention for Black Fathers

NCT03552783
COMPLETED NA

Exergaming in Advanced HF With Multiple Chronic Conditions Prior to LVAD Implantation or Heart Transplant

NCT03580759
COMPLETED Phase 4

Effect of Locally-Applied Simvastatin on Clinical Attachment Level and Alveolar Bone in Periodontal Maintenance Patients

NCT03452891
COMPLETED NA

Modulation of Spontaneous Cortical Activity by tDCS: BRAIN Initiative I

NCT03672747
COMPLETED Phase 1

Biomarker Assessments of Leukine During Treatment of Parkinson's Disease

NCT03790670
← Previous Page 3 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 57
Phase 2 52
Phase 3 10
Phase 4 21

Therapeutic Areas

Peripheral Arterial Disease 7
Lymphoma 6
Breast Cancer 5
Rheumatoid Arthritis 5
Peripheral Artery Disease 3
Multiple Myeloma 3
Healthy 3
Sleep Fragmentation 2
Graft-versus-host Disease (GVHD) 2
Parkinson's Disease 2

What is open in the University of Nebraska pipeline

51 recruiting of 407 indexed (13% open); 261 completed (64%).

Phase mix: 31 late (III/IV) vs 109 early (I/II) (early-phase heavy).

Top condition: Peripheral Arterial Disease (7 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Nebraska: open-pipeline peers nationwide

Peers matched on 407 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%15%20%25% Total trials Recruiting share University of NebraskaCase Comprehensive Cancer CenterTakedaUniversity of Kansas Medical CenterSt. Jude Children's Research HospitalAddario Lung Cancer Medical InstituteAmerican UniversityAnnexonAnsun Biopharma
University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 407 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Nebraska page

407 registered trials is a research-attention snapshot, not an endorsement of University of Nebraska or any single study.

  • 51 of University of Nebraska's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Peripheral Arterial Disease is the condition University of Nebraska studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Peripheral Arterial Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Nebraska pipeline card: 407 registered trials from official public datasets.Report a data error.